The latest closing stock price for CRISPR Therapeutics AG as of March 31, 2025 is 34.03.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $1,415 today, roughly 1 times their original investment - a 11.65% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 67.88, which is 99.5% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 32.96, which is 3.1% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 49.49.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $1,415 today, roughly 1 times their original investment - a 11.65% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 67.88, which is 99.5% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 32.96, which is 3.1% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 49.49.